News

Y-90 radioembolization: A new treatment for hepatic metastases from breast cancer

Yttrium-90 radioembolization is a minimally invasive treatment that may slow disease progression in breast cancer that has metastasized to the liver.

Cancer 'vaccine' for advanced disease shows early progress

Cancer 'vaccine' for advanced disease shows early progress

Early progress has been made in developing a treatment that might one day help the immune system defend itself against cancer, but research is still in preliminary stages.

Clinician-patient relationship tied to health care outcomes

Clinician-patient relationship tied to health care outcomes

Meta-analysis of 13 randomized controlled trials shows small but significant effect from the patient-clinician relationship.

More sensitive testing may better define prognosis and treatment for leukemia

Nearly half of patients with the most common form of adult leukemia may have a distinct pattern of genetic abnormalities that could better define their prognosis and treatment.

Doxorubicin-ifosfamide combo improves progression-free survival in soft-tissue sarcoma

A new European study does not support administration of intensified doxorubicin and ifosfamide for palliation of advanced soft tissue sarcoma.

Patients see sharp increase in price of specialty drugs

Patients see sharp increase in price of specialty drugs

Many Americans paying less for prescription drugs, but some are having to deal with sharp rises in cost of specialty meds.

New gene implicated in progression and recurrence of triple-negative breast cancer

A gene not previously associated with breast cancer appears to play a pivotal role in the growth and progression of triple-negative breast cancer.

Interval tumors found in six percent of colorectal cancer cases

Interval tumors found in six percent of colorectal cancer cases

Interval cancers more likely to be earlier stage, proximal, have lower risk of death

Germline EGFR T790M mutation indicates a high risk for familial NSCLC regardless of smoking

Two studies provide new insight into a germline epidermal growth factor receptor T790M mutation in familial non-small cell lung cancer, and suggest the need for tailored approaches for early detection and treatment.

Reliance on Windows XP may threaten data security

Reliance on Windows XP may threaten data security

Continued security of patient data is needed following Microsoft's termination of XP support.

Conference Coverage

AACR: Irregular Menstrual Cycles Tied to Ovarian Cancer Risk

Irregular menstrual cycles may be an early marker of ovarian cancer risk, according to a study presented at the annual meeting of the American Association for Cancer Research.

AACR: Coffee consumption may lower liver cancer risk

Increased coffee consumption may reduce hepatocellular carcinoma (HCC) risk across ethnicities, according to a study.

AACR: LY2835219 shows promise for metastatic breast cancer

The novel cell cycle inhibitor selective for the cyclin-dependent kinases CDK4 and CDK6 (CDK4/6), LY2835219, shows promise for metastatic breast cancer, according to a study.

Molecular subtyping of breast cancer can better identify women at high risk of recurrence

A method called molecular subtyping can help doctors better determine which of their breast cancer patients are at high risk of getting breast cancer again, according to a new study.

Reducing radiation therapy dose to bilateral submandibular lymph nodes improves salivary function

For head and neck cancer patients undergoing radiation therapy, a reduction in the amount of radiation treatment volume to the submandibular (level IB) lymph nodes resulted in better patient-reported salivary function.

Sign Up for Free e-newsletters

April Contest: Win a Pebble Watch

Start the contest today

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs